This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert J. Petrick, MS, Pharm D; Norman Kronacher, MD; Valiere Alcena, MD

JAMA. 1975;231(8):843-844.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

HAZARDOUS conditions may result from interactions of drugs that can substantially increase or decrease a patient's response to warfarin sodium. The interaction between warfarin and ethacrynic acid has been demonstrated in vitro, but apparently, no clinical evidence has been reported in the literature confirming this. We have had the opportunity to observe a patient taking both warfarin and ethacrynic acid.

Report of a Case

A 38-year-old woman was admitted with known primary pulmonary hypertension diagnosed by cardiac catheterization. As on multiple prior admissions, she had weight gain, shortness of breath, chest discomfort, and belching. She had a two-year history of labile hypertension. During 1972, she developed increased skin pigmentation, elevated blood pressure, and cor pulmonale. Since then, severe failure of the right side of the heart has required several admissions and therapy with extremely high doses of diuretics. A diagnosis of protein-losing enteropathy with hypoalbuminemia was established. Recently, paroxysmal nocturnal . . . [Full Text PDF of this Article]

Author Affiliations
From the departments of pharmacy (Dr. Petrick) and medicine (Drs. Kronacher and Alcena), Montefiore Hospital and Medical Center, Bronx, NY.

Footnotes
Reprint requests to 111 E 210th St, Bronx, NY 10467 (Dr. Petrick).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?